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Abstract
Metabolic fluxes are governed by physical and economic principles. Stationarity constrains them
to a subspace in flux space and thermodynamics makes them lead from higher to lower chemical po-
tentials. At the same time, fluxes in cells represent a compromise between metabolic performance and
enzyme cost. To capture this, some flux prediction methods penalise larger fluxes by heuristic cost
terms. Economic flux analysis, in contrast, postulates a balance between enzyme costs and metabolic
benefits as a necessary condition for fluxes to be realised by kinetic models with optimal enzyme levels.
The constraints are formulated using economic potentials, state variables that capture the enzyme
labour embodied in metabolites. Generally, fluxes must lead from lower to higher economic poten-
tials. This principle, which resembles thermodynamic constraints, can complement stationarity and
thermodynamic constraints in flux analysis. Futile modes, which would be incompatible with eco-
nomic potentials, are defined algebraically and can be systematically removed from flux distributions.
Enzymes that participate in potential futile modes are likely targets of regulation. Economic flux anal-
ysis can predict high-yield and low-yield strategies and captures preemptive expression, multi-objective
optimisation, and flux distributions across several cells living in symbiosis. Inspired by labour value
theories in economics, it justifies and extends the principle of minimal fluxes and provides an intuitive
framework to model the complex interplay of fluxes, metabolic control, and enzyme costs in cells.
Keywords: Flux analysis, Enzyme cost, Cost-benefit analysis, Thermodynamic flux analysis, Futile cycle,
Principle of minimal fluxes, Labour value.
Abbreviations: PFK: phosphofructokinase; FBP: fructose bisphosphatase; ATP: adenosine triphosphate;
ADP: adenosine diphosphate; F6P: fructose 6-phosphate; F16BP: fructose 1,6-bisphosphate; P: phosphate.
1 Introduction
Cells invest a considerable fraction of their proteome in metabolic enzymes. A metabolic network can
support various flux distributions, but only some of them are physically and biologically plausible. Knowing
the underlying principles could help engineer microbes and better understand phenomena like the Warburg
effect in cancer [1]. Flux balance analysis (FBA) [2] and its many variants predict fluxes from assumptions
about stationarity, thermodynamics, metabolic yield, and principles of flux minimisation. A known flux
mode – i.e., active reactions and flux directions – can help restrict the possible flux distributions. Flux
directions can either be constrained ad hoc or based on general principles: thermodynamic laws, for instance,
restrict fluxes to run from higher to lower chemical potentials [3, 4, 5, 6, 7, 8, 9], which make certain cycle
fluxes impossible. Within these physical limits, various flux distributions remain possible and cells can
choose between them, at least partially, by their enzyme abundances. By repressing some enzymes, cells
can disrupt futile cycles and choose between pathways that allow for fast growth or for high yield [10, 11].
Moreover, enzymes compete for available space [12], and their production or presence in cells can lead
to growth defects [13, 14]. Therefore, cells must prioritise the usage of metabolic pathways and balance
their fluxes according to supply and demand, and the choice of metabolic fluxes will reflect a compromise
between metabolic tasks – e.g. production of biomass components – and a limited enzyme capacity.
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Figure 1: Economical fluxes, economic potentials, and a futile cycle. (a) Schematic metabolic pathway with
a production objective (production of metabolite B). In steady state, the production and consumption of
internal metabolites (within box) are balanced. In a kinetic model, an optimisation of enzyme levels would
lead to a steady flux from A to B (unless enzyme expression is too costly to make this flux profitable), while
the other two enzymes are not used. The flux is not only beneficial (providing a positive benefit as a whole),
but also economical (all active enzymes provide individual benefits). We can choose economic potentials
(shades of blue; white represents zero values) such that fluxes leads from lower to higher potentials. (b)
The flux cycle between X and Z provides no benefit and is futile, even though it is thermodynamically
feasible. The flux distribution in (c) – the sum of both flux distributions from (a) and (b) – is beneficial,
but uneconomical because enzyme is wasted for driving the cycle. In (b) and (c), no consistent economic
potentials can be chosen, confirming that the fluxes are not economical.
How can such compromises be described mathematically? In kinetic models [15, 16, 17, 13, 11], optimal
enzyme profiles can be predicted from cost-benefit optimisation: enzyme profiles are scored by metabolic
objective functions – which depend on metabolic fluxes and concentrations – and are penalised by cost
functions [15, 16, 13] or constrained to a maximal sum of enzyme levels [16]. The numerical optimisation
can be difficult and requires detailed kinetic models, which are hard to obtain for large metabolic networks.
To date, only constraint-based models allow for a flux prediction on the genomic scale. In some methods,
the metabolic objective (a linear function of the fluxes) is traded against heuristic flux costs. According
to the principle of minimal fluxes [18, 19], a flux distribution must minimise a heuristic cost function
while achieving a predefined value of the metabolic objective. Flux minimisation avoids futile cycles (what
counts as “futile” depends on the benefit and cost functions chosen) and can prefer low yield/low cost flux
distributions over high yield/high cost strategies. In comparative studies of metabolic objectives [20, 21],
different objective functions were found to be suitable for different growth conditions, and flux costs were
an important factor for flux prediction.
Unfortunately, flux analysis cannot capture the precise relationship between enzyme levels and stationary
fluxes. In penalising fluxes instead of enzyme levels, it implies a simple proportionality between the two,
which would only hold at fixed reactant levels. In reality, stationary fluxes depend on enzyme levels in
complicated ways, and the empirical correlations between the two are rather low [22]. If this is true, how
can flux costs or the principle of minimal fluxes be justified? For instance, can certain flux modes (sets of
active reactions and their signs) be ruled out because they would imply a waste of enzyme in any underlying
kinetic model?
Figure 1 shows an example: if enzyme levels are optimised, the cycle flux will be suppressed no matter which
rate laws or enzyme investment function are used. Metabolic economics, a theory of enzyme-optimal states
in kinetic models, provides general criteria for such economically feasible fluxes [23]. In enzyme-optimal
states, all active enzymes must have a positive control over the metabolic return to balance their costs.
This implies that fluxes must lead from lower to higher economic potentials, state variables representing a
demand for individual metabolites induced by the global objective. Thus, the potentials play a similar role
as the chemical potentials in thermodynamics [24]. Figure 1 (a) shows this clearly: increasing economic
potentials along the pathway flux indicate that the flux distribution is economical. In the futile cycle in
(b), such an increase would be impossible and any pathway flux with this cycle, like in Figure 1 (c), is
uneconomical – even if it provides a positive overall benefit. Mathematically, the economic constraints
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resemble thermodynamic constraints, but hold independently of them: if metabolite C has a high chemical
potential, the cycle in Figure 1 can be thermodynamically feasible, but will still remain futile.
By including the economic constraints into flux analysis, we obtain a physically, biochemically, and eco-
nomically sound theory of metabolic fluxes, called economic flux analysis (EFA). With this framework,
we can address general questions about metabolic strategies. For instance, the metaphor of “currency
metabolites” is often used for metabolites that carry energy or chemical groups between biochemical pro-
cesses. Here we can assign economic values to such metabolites, and to all other substances in the cell.
In reactions or pathways, the costs for maintaining a flux can be broken down into costs for substrates,
cofactors, side products, and enzymes. In comprehensive cell models, the enzyme costs could further be
split into costs for amino acid production, ATP, ribosomes, mRNA, and so on. Knowing their costs, we can
study whether substances should be imported or synthesised by the cell (which will depend on the protein
costs of transporter and pathway and on the value of substrates, cofactors, and energy), and we can claim
that substances that embody large enzyme investments should be used more efficiently (i.e., downstream
of high-cost transporters or pathways, high-yield strategies should be preferred).
This article describes economic flux analysis and some of its applications. I compare and combine the
economic constraints with thermodynamic constraints and discuss how economical fluxes relate to futile
cycles, their biochemical regulation, and choices between alternative pathways. Details are given in the
supplementary information (SI) at www.metabolic-economics.de/metabolic-economics. MATLAB code is
freely available on github [25].
2 Economic flux analysis
Flux balance analysis (FBA) is a method for predicting flux distributions in metabolic networks. The fluxes
need to be stationary and satisfy upper and lower flux bounds. To ensure thermodynamically feasible
fluxes, one may additionally require metabolites to have plausible chemical potentials, whose differences
along reactions predefine the flux directions. With these constraints, the feasible flux distributions form a
non-convex polytope in flux space. Economic flux analysis adds another constraint, related to an economic
usage of enzymes. Like in FBA, we consider a linear benefit function z(v) = zv · v. Flux distributions
can be classified as beneficial (positive benefit zv · v > 0), non-beneficial (zero benefit, satisfying Nz v =(
z
v
·
N
)
v = 0), or costly (negative benefit zv · v < 0). Non-beneficial and costly flux distributions are
called futile. For convenience, the flux gain vector is split into zv = Nx⊤wx + zˆv. One term scores
the net production of external metabolites (Nx is the part of the stoichiometric matrix referring to these
metabolites), the second one scores fluxes directly. The wxj are called economic potentials (of the external
metabolites) and the zˆvl are called direct flux gains
1.
In EFA, we do not use the flux objective for a direct optimisation, like in FBA, but postulate that all active
enzymatic reactions must satisfy a reaction balance
[zˆvl +∆wl] vl = yl (1)
with positive enzyme costs yl. The term in brackets, called flux demand, consists of the direct flux gain zˆ
v
l
and an indirect flux demand ∆wl, that is, an effective demand for metabolite conversion. As the symbol
∆wl =
∑
i nil wi suggests, it depends on the economic potentials wi of reactants. While direct flux gain
zˆvl and external economic potentials w
x
j are predefined by the benefit function, the internal potentials w
c
m
and enzyme costs yl are variables to be determined. Since enzyme costs must be positive, fluxes and
flux demands must have the same signs, so whenever zˆvl = 0, fluxes lead from lower to higher potentials.
Thus, economic potentials tend to increase along the production chain and, in analogy to labour values in
economics, describe the enzyme labour embodied in a metabolite.
1The splitting of zv can be chosen at will. Setting zv = zˆv and wx = 0, we can attribute the flux gains directly
to reactions. In contrast, we may attribute all the benefit to external metabolite production (possibly introducing virtual
metabolites whose potentials wxj are proxies for direct flux gains).
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Figure 2: In economic flux analysis, metabolic fluxes are governed by three principles: stationarity, thermo-
dynamics, and enzyme economy. (a) In stationary state, production and consumption of internal metabo-
lites must be balanced: in the linear pathway shown, all fluxes vl must be equal. (b) Reaction fluxes
must dissipate Gibbs free energy. To ensure a positive entropy production σl per volume, fluxes must
run from higher to lower chemical potentials µi, i.e., along the direction of the thermodynamic force
Θl = −∆µl/RT . (c) In enzyme-optimal states, fluxes and flux demands zˆ
v
l +∆wl must have equal signs,
allowing for positive enzyme costs hul ul. Without direct flux gains zˆ
v
l , fluxes run from lower to higher
economic potentials wi.
In EFA, the reaction balance Eq. (1) appears as a postulate. Why should we assume it? It can be justified in
two ways, based on two different theories. The first justification comes from flux cost minimisation (FCM),
a generalised form of the principle of minimal fluxes [18]. We consider FCM problems with increasing
cost functions H¯(v) (i.e., sign(∂H¯/∂vl) = sign(vl) whenever vl 6= 0) and without flux bounds that, by
themselves, would enforce non-zero fluxes. Any solution to such a problem will satisfy a reaction balance
Eq. (1) with yl ∼ (∂H¯/∂vl) vl and Lagrange multipliers wl associated with the stationarity constraint.
A second, alternative justification comes from kinetic models with optimal enzyme levels as studied in
metabolic economics [23] (see SI S1). In such models, the enzyme levels ul are control variables, chosen to
maximise the difference between a metabolic return g(u) and an enzyme investment h(u). As a condition
for optimal enzyme allocation, the benefit ∂g/∂ lnul = [zˆ
v
l +∆wl] vl and the cost ∂h/∂ lnul = yl of each
enzyme must be balanced, where zˆvl , wl, and yl are defined by derivatives of the return and investment
functions in steady state. In flux analysis, we do not refer to a specific kinetic model, but we may require
that predicted flux distributions should be realisable by some kinetic model in an enzyme-optimal state.
The reaction balance (1) is a necessary condition for this. It guarantees that flux distributions are not only
globally beneficial, but beneficial in every reaction. In this respect, it resembles the flux sign constraint
from thermodynamic analysis, whereby metabolic systems must dissipate Gibbs free energy not only in
total, but in every single reaction.
Given a metabolic network and a flux gain vector zv, how can we determine economic pathway fluxes?
To allow for positive enzyme costs yl, fluxes and flux demands must have equal signs. If the economic
potentials wi were known, they would define the directions of all active fluxes, and the flux signs could be
used as bounds in FBA. In turn, to test whether a given flux distribution v is economical, we can search
for internal potentials wcm such that
sign(zˆvl +∆wl) = sign(vl) (2)
holds for all active enzymatic reactions. Condition (2), the enzyme benefit principle for fluxes, can be
used as a third flux constraint aside from stationarity and thermodynamic feasibility (see Figure 2). With
the thermodynamic driving force Θl = −∆µl = −∆µ
(0)
l − RT
∑
i nil ln ci and the flux demand g
v
l =
zˆvl − ∆wl, and assuming that all reactions are enzyme-catalysed, economic flux analysis simply requires
that sign(vl) = sign(Θl) for all active reactions and sign(vl) = sign(g
v
l ) for all active enzymatic reactions.
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For an even stricter condition, we may put a lower bound yl
min
[zˆvl +∆wl] vl > yl
min (3)
on the flux benefit for all active enzymatic reactions2. Fluxes together with chemical and economic
potentials satisfying the constraints can be computed by mixed-integer programming [27]. In contrast
to chemical potentials, economic potentials are not directly related to metabolite concentrations and can
therefore appear as separate variables.
Under which conditions can Eq. (2) be solved, i.e. for which flux distributions do feasible economic potentials
wci exist? As a necessary and sufficient condition, the flux distribution must be free of futile modes. A
futile mode in v, as defined in [23], is a subset of active reactions in v that can support stationary
futile fluxes with the same flux directions3 as in v. Like the enzyme benefit principle, this definition of
futile modes depends only on flux directions, not on quantitative fluxes. Economical flux distributions,
economic potentials, and futile modes are closely related. Figure 1 shows this: the flux distribution in (a)
is economical because economic potentials can increase along the flux. The flux cycle in (b) and (c) would
require economic potentials that increase around a circle, which is impossible, so the flux cycle must be
uneconomical. A main advantage of the flux cycle criterion is that it is local: flux distributions can be
discarded based on small futile modes, even if the entire flux distribution is not fully known.
Economic flux analysis must comprise all three conditions (stationarity, thermodynamics, and economics).
To be realisable in enzyme-optimal kinetic models, flux distributions must be economical; since the economic
potentials are defined for steady states, the fluxes must be stationary, and thermodynamic correctness is
necessary to ensure that all enzymes have some flux control4. EFA is closely related to FBA with flux
minimisation (SI S1). However, instead of yielding a economical single flux distribution, it can be used for
sampling them (see Figure S1). In FBA with thermodynamic and economic constraints, the chemical and
economic potentials appear as variables, and constraints between them and the fluxes define feasible flux
modes (i.e. patterns of active fluxes and their signs).
EFA selects flux distributions with economically feasible sign patterns. What does this mean geometrically?
In FBA, the nullvectors of the stoichiometric matrix N form a subspace in flux space. The feasible flux
distributions, as points in this space, form a convex polytope, the intersection between the subspace and a
box defined by upper and lower flux bounds. An example is shown in Figure 3. Thermodynamically feasible
flux distributions must show feasible sign patterns, corresponding to segments of flux space, that is, orthants
or their surfaces. By excluding infeasible segments, the constraints reduce the FBA polytope to a polytope
of feasible flux distributions, which can be non-convex. Sampling and optimisation on this polytope is
much harder than on the convex polytope used in FBA. If economic constraints are imposed (Eq. (2)),
more segments may be excluded (see Figure 3). In some cases, both conditions may coincide. In particular,
non-productive flux distributions, which do not produce or consume any (internal or external) metabolites,
are thermodynamically infeasible, and if a production objective is assumed, they are also uneconomical. For
such objectives, the economic constraints make thermodynamic constraints without concentration bounds
2If all fluxes are positive (which we can assume without loss of generality), we obtain the inequalities
zˆ
v
l +∆w
c
l =
h
u
l
r′l
≥
h
u
l
,min
kcatl (1− e
Θl
≥
h
u
l
,min
kcatl
(4)
where r′l is the flux per enzyme level, h
u
l
min is a lower estimate of the enzyme price, kcat is the forward catalytic constant, and
1− e∆G/RT is the thermodynamic efficiency (i.e., the ratio between net flux and partial forward flux [26]). With estimates
for these quantities, we obtain tighter constraints for the flux demand zˆvl +∆wl and for the economic potentials wi therein.
3For a formal definition, we consider stationary flux distributions k (called test modes) on the active region of v. If k is
futile with respect to zv and sign-concordant with v (i.e. fluxes in k and v have the same directions on their common active
reactions), the flux mode sign(k) is a futile mode in v with respect to zv.
4If a metabolic pathway contains an irreversible reaction – whose rate does not depend on the product level at all – the
downstream reactions have no control over the pathway flux. This creates a paradoxical situation: on the one hand, their
enzymes provide no benefit (because the flux does not depend on them). Without the enzymes, on the other hand, the
flux breaks down. In a numerical optimisation, there would be no feasible optimum for the enzyme levels. To prevent such
situations, reversible, thermodynamically feasible rate laws are mandatory in metabolic economics [28].
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Figure 3: Economical flux distributions as points in flux space. (a) Example pathway with flux bounds
−1 < vl < 1. (b) Elementary beneficial (blue) and futile (red) flux modes. (c) Since each reaction flux can
have three possible signs (1, 0, or -1), there are 33 = 27 possible sign patterns, corresponding to segments
of flux space. Only 13 of them can be realised by stationary fluxes (six triangles, six lines, and the central
dot representing v = (0, 0, 0)⊤). The other segments are not intersected by the plane of stationary fluxes.
(d) A linear FBA objective (here, the rate of reaction 1) defines a flux gain vector zˆv = (1, 0, 0)⊤ for
economic flux analysis. Only five modes (those for which v1 > 0) are beneficial (a condition for being free
of flux modes), while all others are excluded. (e) Only three of these (blue triangle and edges A and B)
are sign-orthogonal on the futile cycle (red arrow) and therefore economical. Flux distributions from the
feasible region can be sampled by weighted flux minimisation with random cost weights.
obsolete. Analogies and differences between economic and thermodynamic constraints, cases in which both
constraints coincide, and analogies to Kirchhoff’s laws for electric networks [29, 30] are discussed in SI S2.
The first step in EFA is to choose a metabolic objective (or equivalently, external economic potentials and
direct flux gains)5. Given an objective function, economical flux distributions can be computed in various
ways: by FBA with economic and thermodynamic constraints, by flux cost minimisation, or by choosing
stationary fluxes and removing all futile modes (SI S5.3).
If a flux distribution is given, it will constrain the economic potentials and enzyme costs, but will not
determine them precisely: there are many choices of economic potentials that would satisfy the reaction
balance. Each choice corresponds to possible kinetic models with specific rate laws and investment functions
[23], and for a unique choice, further assumptions and data – for instance, bounds on enzyme prices,
estimated for single enzymes – can be used. There are different possibilities (for details, see SI S5). If
economical fluxes v are given, we can use the flux directions, and possibly bounds on the flux prices
hvl = yl/vl, to obtain linear constraints for the internal economic potentials w
c
m. Lower bounds on flux
prices may be obtained from estimated minimal enzyme prices hul and catalytic constant k
cat
l . With the
constraints Eq. (3), economic potentials can be sampled, optimised, or chosen at will, and the enzyme
costs can be computed from the reaction balance. As a heuristics for choosing the economic potentials
(see SI S5.4), we may assume that all enzymes have similar costs (“principle of uniform enzyme costs”)
or, alternatively, flux prices. The two assumptions are equivalent to assuming uniform enzyme benefits
[zˆvl +∆wl] vl or flux demands zˆ
v
l +∆wl. If estimated enzyme costs are given, we can also choose economic
potentials that, by the resulting flux benefits, approximate these values. The calculation is similar to a
calculation with uniform enzyme costs. Finally, if the fluxes are unknown and feasible enzyme costs yl are
given precisely, the fluxes can be derived from the flux gain condition (see SI S5.6). Feasible sets of enzyme
costs can be obtained by linear projections [23]. The enzyme costs predetermine a set of active fluxes, and
condition (S8), together with the stationarity condition, can be solved numerically for the fluxes and the
economic potentials wcm. Since the flux directions are not predefined, but emerge from the calculation,
solutions are not guaranteed to be thermodynamically feasible. An example is shown in Figure S6 in the SI.
5The rate of biomass production, chosen as an objective, would yield a positive economic potential for biomass while the
economic potentials of other external metabolites vanish. In such objective functions, external metabolites (e.g., nutrients
from the growth medium) are treated as “free gifts of nature”, like natural resources in some economic theories. With such
objectives, there will be no incentive for sustainable, resource-saving behaviour.
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Figure 4: Economic flux analysis applied to central metabolism in S. cerevisiae. (a) Network model com-
prising glycolysis, the TCA cycle, the pentose phosphate pathway, and some side branches. Cofactors
like ATP or NADH are part of the model, but not shown. ATP production is used as the metabolic
objective. Thermodynamically and economically feasible fluxes (arrows) were determined by flux cost min-
imisation. Chemical potentials (white: low, red: high) were determined within constraints. (b) Economic
potentials (blue: high. white: low. pink: negative), computed based on measured enzyme abundances
(used as a proxy for enzyme costs). (c) Enzyme costs. The highest cost and benefit appears in oxidative
phosphorylation (bottom left).
Using these methods, one can compute realistic economic potentials (and possibly flux distributions) under
constraints for enzyme levels, catalytic activities, enzyme costs, and flux prices. Bounds on flux demands
∆wc can be obtained from experimental data [31] (see SI S5.5).
Economic flux distributions obtained by EFA can be realised by kinetic models with enzyme-balanced states
and with specific rate laws and investment functions. Such models can be systematically constructed.
Figure 4 shows an example, a network model of central metabolism in yeast, where ATP production is used
as metabolic objective. Starting from an economical flux distribution (determined by flux minimisation),
chemical and economical potentials are constructed based on heuristic assumptions [23]. In the calculation,
knowledge about enzyme levels, protein sizes, and catalytic constants can be employed. Given the economic
potentials, a variety of kinetic models is still possible. To obtain specific models, economic loads and
reaction elasticities are chosen in agreement with the compound balance, and rate constants are computed
from them (see [23] and SI S3.4). The resulting models are kinetically and economically plausible and
can serve as starting points for studies on optimal metabolic behaviour, e.g., enzyme adaption to external
perturbations [17].
Methods like FBA and flux cost minimisation (FCM) assume that the metabolic objective – e.g. the rate
of biomass production – depends only on fluxes. In reality, a cell’s fitness will also depend on metabolite
levels. This can create crucial trade-offs: high levels of intermediates may be required for large fluxes, but
may also entail a high osmolarity and a high loss by dilution [32], and some compounds may be toxic at
high concentrations. An economic theory of metabolism should include concentration benefits and show
how they affect the flux distributions. Since FBA deals only with fluxes, it cannot capture such trade-offs.
Metabolic economics, in contrast, considers flux and concentration gains and their coupling in kinetic
models and fully accounts for these trade-offs. Nevertheless, fluxes and concentrations (represented by
economic potentials or loads) are governed by different gain conditions and balance equations and can be
studied separately.
In EFA, we focus on fluxes, so the relevant variables are economic potentials and flux demands. Since
compound gains zci = ∂z/∂ci do not explicitly appear in the reaction balance equation, they can be ignored
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in EFA (but are still captured, implicitly, by the values of economic potentials). Since EFA and FCM are
equivalent, it follows that FCM, even if its fitness function ignores metabolite concentrations, is consistent
with models that consider fitness effects of concentrations. In models with dilution, however, concentration
gains can explicitly appear in EFA: in such models, intermediates are diluted at a rate proportional to their
own concentrations, and this requires a positive production (instead of a zero balance, the usual stationarity
condition). Since dilution fluxes and concentrations are directly coupled, concentration objectives can be
formulated as production objectives and vice versa, and concentration gains zci can be rewritten as flux
gains zvl for usage in FBA.
3 Futile cycles and enzyme regulation
If all metabolic enzymes of a cell were expressed together, futile cycles could easily arise. To prevent
this, potential futile modes must be blocked by repressing some of the enzymes. As an example, consider
the enzymes phosphofructokinase (PFK) and fructose bisphosphatase (FBP) in upper glycolysis (Figures
4 and 5). PFK transfers phosphate from ATP to fructose 6-phosphate (F6P), converting it into fructose
1,6-bisphosphate (F16BP). FBP catalyses the reverse reaction, but instead of producing ATP it releases
inorganic phosphate. Together, the enzymes would drive a substrate cycle that splits ATP into ADP and
phosphate and produces heat (see Figure 5). Cells normally avoid this by repressing one of the enzymes
(see for instance [33]).
Unlike previous verbal or topological definitions, the algebraic definition of futile cycles by futile test modes
leads to clear mathematical statements: a flux distribution with futile modes is uneconomical and cannot
appear in enzyme-optimal states. Futile modes need not be cycles, but may also be linear pathways
without a valuable product. Futile cycles can cause two types of problems: wasting enzyme resources
without a metabolic advantage, or even entailing a metabolic disadvantage like the futile PFK-FBP loop
which degrades ATP. In EFA, the two problems appear in the form of non-beneficial and wasteful cycles. In
reality, cells may accept a waste of enzyme resources (e.g., expressing FBP preemptively, as a preparation
for possible flux reversals), but avoid the waste of cofactors (in this case, by inhibiting FBP allosterically).
In economic flux analysis, the contrary regulation of PFK and FBP is explained by a need to avoid the
futile cycle. Let us study the possible flux distributions (see Figure 5). If ATP (plus water) has a higher
economic potential than ADP (plus phosphate) and if there are no direct flux gains, the PFK-FBP cycle
is futile and all flux distributions containing it are uneconomical. Since all fitness demands are subsumed
in the economic potentials, it does not matter if ATP, ADP, and phosphate are modelled as external or
internal, and the surrounding network need not even be known. Running in reverse direction, the cycle
would produce ATP. However, this would require an unphysiological drop in chemical potential between
F16BP and F6P. Taken together, thermodynamic and economic constraints imply that only one of the
reactions can be active at a time.
Non-beneficial flux distributions are important in EFA because they can be used as test modes to define
futile modes. Enumerating them can be hard because of their large number: for instance, any two flux
distributions can be linearly combined to yield a non-beneficial flux distribution. However, to rule out
futile modes, we can restrict ourselves to elementary non-beneficial test modes, i.e., non-beneficial modes
that contain no smaller non-beneficial modes. This definition resembles the definitions of elementary flux
modes [34, 5]. Elementary costly or multi-objective modes (which must satisfy
(
A
N
)
k = 0 with some
matrix A) are defined accordingly. For small networks, it is possible to enumerate all elementary futile test
modes. The model of yeast central metabolism shown in Figure 6 contains 303894 elementary futile modes.
Many of them are large, comprising up to 42 reactions (calculation using efmtool [35, 36]). Enzymes that
participate in many futile modes are plausible targets for regulation because their repression would disrupt
many modes at once (see Figure 6 (d)). In the yeast model, PFK and FBP rank among the top candidates
for regulation.
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Figure 5: A futile cycle in upper glycolysis can be excluded by economic and thermodynamic constraints.
(a) The enzymes phosphofructokinase (PFK) and fructose bisphosphatase (FBP) can form a futile cycle.
(b) Feasible flux patterns. PFK is only used in glycolysis, FBP only in gluconeogenesis. Both flux modes are
economical and thermodynamically feasible, and consistent economic potentials wATP > wADP+wphosphate
(shades of blue) can be assigned. (c) Infeasible flux patterns. The first cycle degrades ATP and is usually
suppressed. If the economic potentials decrease from ATP to ADP and if there is no direct flux gain (e.g.,
for heat production), the cycle is futile. The cycle in reverse direction would regenerate ATP, but it is
thermodynamically infeasible at physiological reactant levels (chemical potentials shown in red).
Futile modes show which reactions make a flux distribution uneconomical. If a futile mode has been found
in a flux distribution, it can be eliminated by subtracting the corresponding test mode k, yielding the new
flux distribution v − λk. The prefactor λ is chosen such that one flux in the mode vanishes, but no flux
changes its direction: this breaks the mode and keeps the flux distribution thermodynamically feasible. As
an example, consider the flux distribution in Figure 1 (c). To remove the cycles, we subtract the elementary
flux distribution shown in (b) and obtain the mode shown in (a). The fluxes change only slightly, remain
thermodynamically feasible, and become economical. Several futile modes could be removed one after the
other (see SI S5.3), and thermodynamically infeasible modes can be removed in a similar way [37].
Although substrate cycles waste resources – this is why we call them futile – they exist in cells. An example
is autophagy, during which the same proteins may be degraded and produced. Futile cycles in metabolism
are often explained by beneficial side effects, like heat production or a preparation for future flux reversals.
Whether a flux distribution appears to be futile depends on the fitness function assumed. For instance, with
a production objective (e.g., biomass production as the only objective), any non-productive test mode k
(satisfying wx⊤ Nx k = 0) will define a futile mode. However, if we count heat production as a beneficial
side effect (e.g., a higher temperature in a compost pile inhabited by bacteria can speed up biochemical
processes) and include it in our objective, each reaction obtains an additional flux gain −γ∆µl vl (where
γ scores the relative benefit of heat production), and previously futile modes may become beneficial.
Some modes that look futile, but are actually not, are caused by non-enzymatic reactions. If compounds
are non-enzymatically degraded, enzymes may have to produce them constantly to keep them at desirable
levels. If we observed this flux pattern, not knowing that the degradation is non-enzymatic, the simultaneous
production and consumption would appear futile. However, if the degradation cannot be avoided, the flux
distribution will be economical. The definition of futile modes and economical fluxes accounts for such
cases, and pseudo-futile modes are correctly classified as economical (see [23]).
Let us assume that all fitness effects and non-enzymatic reactions are considered in a model. Among the
futile modes, some will be thermodynamically infeasible, but all others need to be disrupted by enzyme
repression. If an enzyme participates in many possible modes, it will be a plausible target of transcriptional
or posttranscriptional regulation. Such enzymes can be found by screening the network for elementary futile
test modes. When cells switch between two flux distributions (e.g., from glycolysis to gluconeogenesis in
the PFK-FBP system), there exists an intermediate range of enzyme levels where a futile cycle could arise.
This can be partially avoided if the enzymes are controlled by a bistable switch (in their transcriptional or
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Figure 6: Futile cycles in central metabolism of the yeast S. cerevisiae (model as in Figure 4). The
network contains two elementary non-productive cycles (indicators of thermodynamically infeasible flux
distributions) and 303894 elementary futile modes (all of them are thermodynamically feasible). (a) An
elementary futile cycle (shown by arrows) produces ATP in oxidative phosphorylation (bottom left) and
consumes it in the PFK/FBP cycle (see Figure 5). (b) Size distribution of elementary futile modes. (c) A
reaction participates in a certain number of elementary futile cycles. These numbers are shown by shades
of blue (white: 0; dark blue: 10). For clarity, only modes up to size 10 are considered. Reactions with
large count numbers (dark blue) are plausible targets of regulation.
post-transcriptional regulation).
Futile modes may not only be suppressed by regulation, but also selected against during evolution. In
evolved metabolic networks, we can expect an avoidance of futile, thermodynamically feasible flux modes.
Only enzymes and pathways involved in at least one beneficial flux mode should exist. If a futile mode
contained only one disruptible enzyme, the enzyme would have to be repressed constantly. Therefore,
potential futile modes should contain at least two disruptible enzymes, and these should show mutually
exclusive expression like in the PFK-FBP system. A systematic detection of futile modes can be helpful
for automatic metabolic network reconstruction.
4 Flux costs and choices between flux distributions
According to EFA and related flux analysis methods [18, 38, 21, 39], the choice between alternative
pathways depends on enzyme costs. In contrast to FBA and FCM, kinetic models relate fluxes to rate
laws, enzyme profiles, and reactant levels and can account for enzyme saturation and allosteric regulation.
Taken as a biological assumption, minimisation of enzyme levels is more plausible than minimisation of
fluxes and allows us to make explicit assumptions about enzyme prices, kinetic mechanisms and metabolic
objectives. By capturing the compromises between pathways, between benefit and cost, and between
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Figure 7: Choice between metabolic strategies. (a) Schematic model of central metabolism comprising
glycolysis, respiration, and an export of incompletely oxidised metabolites (e.g. lactate or ethanol). The
metabolic objective scores the production of A (representing ATP). (b) FBA favours the respiration pathway
because of its higher yield (i.e. the amount of A produced per amount of B). Enzyme costs yl and
economic potentials wi are shown as numbers and by shades of blue. (c) Low-yield fermentation flux.
The intermediate C has a negative economic potential (pink as in Figure 4), and the zero potential of
metabolite E is reached by a positive investment in the export. If both flux distributions are compared
at equal ATP production rates (two-fold influx in (c)), their total enzyme benefit (and total cost) will be
equal. A numerical enzyme optimisation in kinetic models would yield one of the pathway fluxes shown,
or some linear combination.
different objectives, EFA can address questions like the following: If the activity of an enzyme is perturbed
(e.g., by mutation or knock-down), should the other enzymes in the pathway be upregulated (to keep
the flux constant) or downregulated (and compensated by other pathways)? What determines the choice
between yield-maximising and rate-maximising strategies (see Figure 7)? How does this choice depend on
previous investments in the substrate (see Figure 8)? Other methods would assess this on a case-by-case
basis. Economic flux analysis explains more generally how enzyme costs, flux demands, and the choice of
fluxes affect each other.
However, the different approaches are tightly related. Both economic flux analysis and flux cost minimi-
sation (FCM) [18, 19] predict metabolic flux distributions (and thus, the usage of pathways) and trade
metabolic benefit against enzyme cost. Despite their different concepts and assumptions, EFA and FCM
constrain flux distributions in similar ways [23]. Using FCM with variable cost functions, we can generate
many flux distributions for a given network. If no fluxes are enforced by flux bounds, all these flux distribu-
tions will be economical, and the Lagrange multipliers arising from the stationarity constraints can play the
role of economic potentials. On the contrary, any economical flux distribution can be obtained by a flux
cost minimisation with appropriate flux cost functions. From a geometrical point of view, the benefit prin-
ciple defines a set of economically feasible segments in flux space; intersecting them with the FBA-feasible
flux polytope PFBA yields a non-convex polytope PEFA of economical flux distributions. The solutions
of FCM fall into this polytope and fill it completely. Since EFA and flux cost minimisation (with variable
cost weights) are equivalent, their advantages can be combined. EFA provides a theoretical justification
for FCM, and FCM (with randomly sampled cost weights and without flux-enforcing constraints) can be
used to generate economical, thermodynamically feasible flux distributions. The advantage of FCM is that
it uses convex optimisation, which is easier to perform than solving the reaction balance for v and w (by
mixed-integer linear programming) or enumerating the flux cycles in large networks. Once a feasible flux
distribution has been obtained, other flux distributions with the same signs can be easily sampled.
According to EFA, the usage of enzymes and pathways and the choices between them depend crucially
on the enzyme demands, and thus on the economic potentials of substrates and products. For instance,
since isoenzymes catalyse one reaction, they share the same flux demand. If cells behave strictly optimally,
isoenzymes could only be active if their flux prices
∑
l h
u
l ul/vl were equal. If we pick a kinetic model
randomly and optimise its enzyme levels, this is unlikely (unless both isoenzymes have identical kinetic
properties). Thus, if cells behave strictly optimally, they must choose between isoenzymes instead of using
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Figure 8: The choice between high-yield and low-yield strategies depends on enzyme investment embodied
in metabolites. (a) Pathway from Figure 7, with an additional transport reaction. Due to previous enzyme
investments, the intermediate C has a positive economic potential and exporting it would be wasteful.
Only a yield-efficient usage can be economical. (b) With a cheaper transporter, the potential of C can
be negative, and a (yield-inefficient) export strategy can be economical. The transporter’s price could be
estimated from molecule properties like catalytic constant and protein size. The underlying principle –
valuable metabolites should be used efficiently – may hold very generally.
them in combination. If a cost-efficient enzyme is expressed, it fixes the flux demand at a low value
and suppresses the usage of less cost-efficient isoenzymes. However, if the first enzyme disappears (e.g.,
by a knock-out), the flux demand can rise, allowing other isoenzymes to be used. The same holds for
“isopathways”, i.e. pathways with the same overall stoichiometries. It is clear that cells are not bound to
follow these rules and that other demands (e.g., being prepared for unforseen changes) can override a strict
cost-optimality.
Pathway fluxes with lower yields may entail larger thermodynamic forces, and thus lower required enzyme
levels, effectively leading to larger production rates than yield-efficient modes. FBA, by construction,
favours high-yield fluxes. Flux optimisation, with its predefined flux cost function, favours short pathways,
possibly are the expense of a lower yield. Usage of individual cost weights can lead to other – high-yield
or low-yield – solutions, covering all flux distributions that satisfy the reaction balance. Figure 7 shows
an example. The scheme of central metabolism represents glycolysis, respiration, and the export of an
incompletely oxidised metabolite like pyruvate, lactate, or ethanol. FBA would favour respiration because
of its higher ATP yield per mole of glucose. EFA can allow for respiration, fermentation flux (which
may have larger ATP production per enzyme investment), and convex combinations of both. In case
(b), metabolite C has a positive economic potential, but can still be beneficially converted into the more
valuable A. With the flux shown in (c), its economic potential must be negative because its export is costly
and leads to a zero economic potential.
Flux analysis can be applied to multi-objective problems. In flux analysis, Pareto optimality has been
used to describe trade-offs between precursor production, ATP production, and small fluxes in central
metabolism [21]. Multi-objective problems can be also be addressed in economic flux analysis. Mixed
objective functions can join several terms including individual enzyme costs, effective gains arising from
hard constraints, and economic imbalance terms used to describe non-optimal enzyme levels. If objectives
are uncertain or rapidly changing, it can be an optimal control strategy to adapt the enzyme levels to the
expected or time-averaged objective. We just have to assume a flux gain zv =
∑
n pn z
v
(n), where the
pn are probabilities or relative durations of different objectives, and the z
v
(n) are the corresponding flux
gain vectors. Compromises between opposing objectives can be described by Pareto optimality [21]. Any
Pareto-optimal flux distribution is also an optimum for some convex mixture of the objectives – which can
be treated by EFA.
A simultaneous optimisation of several objectives – comparable to simultaneous compliance with thermo-
dynamic and economic constraints – may have no solution. However, it may be suitable to describe social
behaviour like symbiosis. In Figure 9, two cells with different objective functions share a flux distribution
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Figure 9: Flux distribution between two cells living in symbiosis (schematic model). (a) Cells A and B
exchange metabolites needed for their biomass production. (b) Internal metabolites in the model (shaded)
must be balanced. (c) Biomass production in cell A, seen as a metabolic objective, defines a set of
economic potentials (shades of red). All reactions within cell A (red arrows) must satisfy the economic
balance equation for these potentials. (d) The same holds for cell B and the economic potentials for its
own biomass production (shades of blue). In the resulting state, none of the cells would profit from small
variations of its enzyme levels: the flux distribution is evolutionarily stable.
that, within each cell, complies with the cell’s own objective. As a condition for such evolutionarily stable
fluxes, the economic balance equations must hold within each cell for the respective objective. EFA can
also be extended to describe a “division of labour” between different flux distributions in one cell, realised
in different spatial or temporal compartments. In this case, the same reactions can appear several times
in diferent compartments, with different fluxes (see Figure S3 in SI). A specialisation of flux distributions
can make metabolism more efficient, because compartments can establish different conditions (chemical
and economic potentials) allowing for different flux directions or different cost-efficient uses of enzymes.
Although all economic variables are derived from one metabolic objective, we can analyse each compart-
ment separately. In each compartment, the economic potentials on the boundary define a local objective
for this compartment.
5 Discussion
Biological structures like the shapes of trees and bones (see SI S3.3), the structure and dynamics of bio-
chemical networks, and even chemical properties of biomolecules can be studied in terms of functional
adaption. If enzyme levels in metabolic networks are optimised, this shapes the fluxes in specific ways.
Metabolic economics [23] helps us explore this hypothesis under realistic assumptions about reaction ki-
netics, metabolic objectives, and enzyme costs. The demand for metabolites and enzymes (that is: their
beneficial effect for the cell) is subsumed in economic potentials and enzyme demands. Economic flux
analysis uses these concepts for flux prediction. It relies on three principles: stationarity, dissipation of
Gibbs free energy, and economically chosen enzyme levels. Interestingly, thermodynamic and economic
constraints show many analogies: both can be derived from a common variational principle, constrain flux
directions by potential differences, exclude flux cycles, and resemble Kirchhoff’s laws for electric circuits
[29]. Similarities and dependencies between economic and thermodynamic constraints are discussed in
detail in SI S2.
Flux analysis methods like flux minimisation and FBA with molecular crowding describe compromises
between enzyme investments by hypothetical flux costs. Why should one care about the reaction balance
equation, which contains additional variables and is harder to solve? Unlike flux minimisation, the reaction
balance is firmly based on kinetic models and the economic variables can be derived from metabolic
control analysis. The economic potentials, which subsume rate laws and metabolic objective, provide a
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new layer of abstraction between kinetic models and flux analysis, linking the optimality concepts between
both approaches. EFA captures common assumptions about flux costs and benefits, enzyme costs, and
numerical enzyme optimisation, and provides general principles for economical fluxes. Futile cycles are not
just suppressed as a side effect of a numerical optimisation (like in flux cost minimisation), but can be
systematically detected and removed, like the cycles in thermodynamic flux analysis [40, 41]. This can be
useful in metabolic network reconstruction. Since FCM (with variable cost functions) is equivalent to EFA,
it is proven to be consistent with an optimal use of enzymes. The comparison also shows that metabolic
objective and flux costs in FCM correspond to marginal quantities in kinetic models, the benefits and
enzyme costs (see SI S2.5).
If we think of a cell’s entire metabolic network and assume that biomass needs to be produced, all enzymes
should at least indirectly contribute to this objective. To compute optimal enzyme profiles on this scale,
we would need kinetic models much larger than existing models today. However, if all enzyme levels
in a network are optimal, this must also hold for every pathway and every reaction within the network.
Accordingly, if a flux distribution is economical, it must be locally beneficial in every reaction. On the
contrary, the reaction balance can be summed over several reactions and thus be extended to pathways
with arbitrarily drawn borders. This allows us to focus on individual pathways, keeping in mind that they
are embedded in a larger network. The fact that global benefits can be written in terms of local economic
potentials is very practical. In particular, the metabolic objectives of the larger network can be subsumed
in the economic potentials at the boundaries of pathways. With their help, an enzyme’s overall benefit
∂g/∂ul effects can be represented as a local production of value within the pathways. Together, the
flux benefits of all reactions add up to the overall benefit zv · v. Relations between fluxes and economic
potentials in larger networks are discussed at length in SI S3.4: that flux demands must exceed a critical
value (defined by molecular properties of the enzymes, and how this shapes the usage of enzymes); how
the laws for enzyme investment can be extended from reactions to pathways; and how metabolic objectives
for individual pathways can be established.
In each pathway, the internal economic state will depend on the economic potentials on its boundaries.
Comparable to boundary conditions in partial differential equations, these potentials represent a pathway’s
interaction with the outside world, i.e., the rest of the network. This can help us dissect networks into
pathways linked by “communicating” metabolites, whose concentrations, production rates, and economic
potentials are the connecting variables. If we prepare pathway models such that fluxes, chemical potentials,
and economic potentials at their boundaries match , they can be directly combined. Thus, like in modular
response analysis [42], we can study pathways separately, knowing how they will interact in the larger
network.
The usage of economic potentials as connecting variables is helpful not only for modelling, but also to
understand biological regulation. If the usage of enzymes or pathways depends on the economic potentials
of some key metabolites, e.g. cofactors and precursor molecules, these potentials will be ideal input signals
for controlling the enzymes’ activities. For instance, a hypothetical gene regulation function could respond
to the economic potentials of substrates and products, encoding the current demand for the enzyme: an
enzyme could be repressed if its flux demand falls below the critical value set by the enzyme’s minimal price.
Of course, economic potentials cannot be sensed biochemically – but metabolite levels could represent them
as biochemical signals. Similarly, permanent mismatches between flux benefit and enzyme cost (“economic
imbalance”) may lead to selection pressures on the enzyme’s gene regulation function.
For a comprehensive view of enzyme investments in a cell, one may classify the enzymes hierarchically into
pathways and pathways into larger categories, which together form the metabolic network. Since enzyme
costs are positive and additive, they can be treated like amounts. In the branches of the hierarchy, a
fraction is devoted to metabolism, a smaller fraction of this to glycolysis, and finally to each glycolytic
enzyme. Normalised to a sum of 1, the costs form a measure in the mathematical sense on the enzyme
hierarchy. Such hierarchical enzyme costs may be visualised similar to protein abundances by treemaps (see
www.protemaps.net), picturing the enzyme economy of a cell in a comprehensive and detailed way. Under
the optimality assumption, the same picture will also describe the enzyme benefits, i.e., the scaled control
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that each enzyme exerts over the metabolic objective. The fact that the can be displayed as amounts
may sound surprising (because they are response coefficients ∂g/∂ lnul, which generally can be negative).
However, in enzyme-optimal states, the benefit principle ensures their positivity.
Since resources like nutrients, energy, and space are limited, cells cannot run all biochemical processes
at full speed, but need to prioritise and balance them. Not surprisingly, EFA borrows concepts like cost,
benefit, or Pareto optimality from economics, which is typically concerned with opposing needs. According
to the reaction balance, a metabolite’s economic potential embodies the enzyme investment that is needed
for its continuous production. This resembles the concept of labour value, the necessary labour invested in
the production of a commodity (see SI S2.6). Since demands and prices in metabolic economics are defined
as marginal quantities (i.e. assuming small changes of the current state), enzyme costs do not correspond
to labour values in the classical sense (the average time investment needed for an item produced), but
to a marginal form of labour values (the extra time investment needed to increase the production by one
item). The cost-benefit balance for enzyme levels resembles a marginal decision rule, stating that goods
or services should be consumed at quantities at which marginal benefits and costs match [43]. The global
metabolic objective function is locally represented by economic potentials, which resemble the prices of
goods and services in neoclassical value theory. On the contrary, the calculation of consistent economic
potentials in metabolic networks resembles the calculation of consistent prices for planned economies, and
similar mathematical methods could be used in both cases.
EFA could be experimentally tested on metabolic pathways under strong selection pressure. As a testable
prediction, substances in which much has been invested (e.g., using costly transporters for small molecules,
or costly machinery for macromolecule synthesis) should be used efficiently. Quantitatively, one could
measure the economic potentials of substances by finding the break-even point for transporter costs at
which transporters start to be used. Differences of economic potentials along pathways, defined in this
way, should be balanced with the prices of enzymes within the pathways. Testing this requires precise
measurements of enzyme costs, and since we are concerned with optimal states, a previous evolution in the
lab [13, 44]. Enzyme prices could be measured by assessing artificial protein expression [13, 14] or the effects
of increased protein costs (e.g. by nitrogen depletion or inhibitors of translation). Economic cell models
would generally profit from precise measurements of enzyme levels, catalytic constants, and enzyme costs
at different growth rates. Furthermore, it would be interesting to relate an enzyme’s calculated economic
imbalance to measured rates of evolutionary change for the enzyme level.
Metabolic economics could be extended from metabolism of small molecules to all reactions in growing
cells, including macromolecule synthesis. Explicit investment functions would become obsolete in this case
because costs of protein and ribosome production would automatically arise from demands for precursor
molecules. Finally, to account for changing environments and anticipation of future events [23], one
might consider complex fitness functions, comprising not just the current metabolic task, but probabilistic
mixtures of future tasks. The resulting bet-hatching strategies [45, 46] could explain observed behaviour like
preemptive expression of enzymes (and their allosteric inhibition), or the production of storage compounds
like starch or glycogen. Experimental studies of such processes would require an artificial evolution in
variable environments.
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